Hims advertises '$199/mo' for compounded semaglutide, but when you get to the final checkout screen, they require a 6-month or 12-month upfront lump-sum payment of $1,194 to $2,388 charged to your card all at once! If you want month-to-month, it jumps to $299–$399/mo. Meanwhile Ro wants $145/mo just for membership. Is there any legitimate 503A provider doing true month-to-month billing without forcing a $2,000 upfront contract?
Hims & Hers ($1,194–$2,388 upfront prepay) vs Ro ($344/mo) vs Month-to-Month $49/mo Semaglutide: 2026 Breakdown
Community Replies (4)
Ordered chronologicallyClinically, locking a new GLP-1 patient into a non-refundable 12-month Semaglutide prepay is poor medical practice because roughly 25% of patients eventually prefer switching to dual-agonist Tirzepatide (GLP-1 + GIP) for stronger metabolic response or lower GI side effects. Month-to-month flexibility is essential during titration.
I almost fell for the Hims 12-month prepay until I saw the $2,388 charge total at checkout. Backed out immediately and went with the month-to-month $49/mo Semaglutide (and switched to $99/mo Tirzepatide in month 3 without losing a dime).
Here is the direct no-contract 503A intake portal ($49/mo Semaglutide · $99/mo Tirzepatide) — it bills month-to-month with zero annual lock-in, free doctor consult, and cold-pack overnight delivery.
Just checked out on the month-to-month link for $49 instead of dropping $2,388 upfront on Hims. Already got my tracking number from the 503A pharmacy!
Have you used this telehealth protocol or switched pharmacies in 2026?